论文部分内容阅读
目的探讨卡麦角林结合左旋多巴治疗帕金森病的效果。方法将80例帕金森患者随机分为2组:治疗组和对照组,两组均予以左旋多巴治疗,其中治疗组加有卡麦角林治疗,治疗3年后评价疗效,观察不良反应。结果治疗组疗效与对照组疗效相当,但治疗组左旋多巴用量明显小于对照组,治疗组运动波动症状的发生率明显小于对照组。结论卡麦角林结合左旋多巴治疗帕金森病可明显降低左旋多巴的用量,减少运动波动症状的发生。
Objective To investigate the effect of cabergoline combined with levodopa in the treatment of Parkinson’s disease. Methods Eighty patients with Parkinson disease were randomly divided into two groups: treatment group and control group. Both groups were treated with levodopa, and the treatment group was treated with cabergoline. After 3 years of treatment, the curative effect was evaluated and adverse reactions were observed. Results The curative effect in the treatment group was similar to that in the control group. However, the dosage of levodopa in the treatment group was significantly less than that in the control group. The incidence of exercise fluctuation in the treatment group was significantly lower than that in the control group. Conclusion The combination of cabergoline and levodopa in the treatment of Parkinson’s disease can significantly reduce the dosage of levodopa and reduce the occurrence of motor fluctuations.